1,000 times higher sensitivity for doping testing available now

Chimera Biotec and German Sports University developed a new and extremely sensitive technology for anti-doping testing


Dr. Michael Adler, head of R&D at Chimera Biotec GmbH, Dortmund, Germany, and his group develop an ultra sensitive test for the detection of myostatin doping together with the team of Dr. Patrick Diel at the German Sports University, Cologne, Germany. The project, using Chimera IMPERACER plattform, is sponsored by the World Anti-Doping Agency (WADA) in Montreal, Canada.

According to several experts, doping consumers are seeking to misuse substances that influence the myostatin level. There are several ways for myostatin doping: First by using drugs, which influence the signal transduction of myostatins directly and second by influencing genes, which regulate the myostatin level (gene doping). The myostatin protein belongs to the family of growth hormones and has significant influence on the skeleton muscles. Researchers found that a blockade of signal transduction of myostatins causes an immense growth of muscles.

Other news from the department research and development

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy